Fundación Cardiovascular de Colombia

Academic/HospitalWebsite ↗

Also known as: Fundacion Cardiovascular | Fundacion Cardiovascular de Colombia | Fundación Cardiovascular de Colombia | Research Institute/Fundación Cardiovascular de Colombia

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Jul 1, 2003

Last known activity

Aug 3, 2020

Timeline

1980s

Jan 1, 1986
Fundación Cardiovascular de Colombia— Founded

Drugs by trial phase (9 distinct, 7 trials)

Phase 4 (1 own, 0 via acquisition)

candesartan

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

COVID-19 convalescent plasma

Other trials (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT04377386Lead sponsorN/AAug 3, 2020
NCT04480632Lead sponsorPhase 2Aug 1, 2020
NCT03813225Overall official - principal investigatorN/AJan 15, 2019
NCT03813225Lead sponsorN/AJan 15, 2019
NCT00319202Study chairPhase 4Jun 1, 2006
NCT00319202Lead sponsorPhase 4Jun 1, 2006
NCT00319202Overall official - principal investigatorPhase 4Jun 1, 2006
NCT00317629Lead sponsorPhase 3May 1, 2006
NCT00317629Study chairPhase 3May 1, 2006
NCT00428727Study chairPhase 3Jan 1, 2005
NCT00428727Overall official - principal investigatorPhase 3Jan 1, 2005
NCT00428727Lead sponsorPhase 3Jan 1, 2005
NCT00323973Lead sponsorPhase 3Jul 1, 2003
NCT00323973Overall official - principal investigatorPhase 3Jul 1, 2003

Details

Founded: Bucaramanga, CO Jan 1, 1986
Last known activity: Aug 3, 2020